Sabine Haubenreisser holds a Master in Pharmaceutical Science, a Ph.D. in Pharmacology and a certificate in Epidemiology. In 1997 she joined the European Medicines Agency (EMA), where she held positions as support to the Head of Human Unit, as Project Manager in the Sector of New Chemical Substances, as Secretary to the Mutual Recognition Facilitation Group and from 2001 to 2009 as Specialised Group Leader of the Team Anti-Infectives, Immunology, Gastroenterology and Musculoskeletal in the Post-Authorisation Human Unit. From 2009 to 2012 she worked as Officer for External Communications and Media in the Office of the Executive Director, where she developed communication strategies and prepared EMA public communications, involving collaboration and coordination with a wide range of parties within the Agency, CHMP members and scientific experts. From 2009 to 2012 she was the EMA alternate technical coordinator for ICH. On 1 May 2012 she was appointed as Liaison Official at the U.S. FDA and took up office in White Oak Silver Spring on 16 July 2012.